Emyria Management
Management criteria checks 4/4
Emyria's CEO is Michael Winlo, appointed in Nov 2019, has a tenure of 5.17 years. total yearly compensation is A$542.07K, comprised of 70.1% salary and 29.9% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth A$35.58K. The average tenure of the management team and the board of directors is 5.2 years and 3.9 years respectively.
Key information
Michael Winlo
Chief executive officer
AU$542.1k
Total compensation
| CEO salary percentage | 70.1% |
| CEO tenure | 5.2yrs |
| CEO ownership | 0.2% |
| Management average tenure | 5.2yrs |
| Board average tenure | 3.9yrs |
Recent management updates
Recent updates
Will Emyria (ASX:EMD) Spend Its Cash Wisely?
Feb 02
We're Hopeful That Emyria (ASX:EMD) Will Use Its Cash Wisely
May 20Here's Why We're Not Too Worried About Emyria's (ASX:EMD) Cash Burn Situation
Oct 20We Think Emyria (ASX:EMD) Needs To Drive Business Growth Carefully
Jun 11Will Emyria (ASX:EMD) Spend Its Cash Wisely?
Feb 25Need To Know: Emyria Limited (ASX:EMD) Insiders Have Been Buying Shares
Nov 17CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$542k | AU$380k | -AU$11m |
| Mar 31 2024 | n/a | n/a | -AU$12m |
| Dec 31 2023 | n/a | n/a | -AU$12m |
| Sep 30 2023 | n/a | n/a | -AU$9m |
| Jun 30 2023 | AU$620k | AU$380k | -AU$5m |
| Mar 31 2023 | n/a | n/a | -AU$6m |
| Dec 31 2022 | n/a | n/a | -AU$8m |
| Sep 30 2022 | n/a | n/a | -AU$7m |
| Jun 30 2022 | AU$615k | AU$486k | -AU$7m |
| Mar 31 2022 | n/a | n/a | -AU$7m |
| Dec 31 2021 | n/a | n/a | -AU$6m |
| Sep 30 2021 | n/a | n/a | -AU$6m |
| Jun 30 2021 | AU$471k | AU$350k | -AU$5m |
| Mar 31 2021 | n/a | n/a | -AU$5m |
| Dec 31 2020 | n/a | n/a | -AU$5m |
| Sep 30 2020 | n/a | n/a | -AU$5m |
| Jun 30 2020 | AU$506k | AU$362k | -AU$5m |
Compensation vs Market: Michael's total compensation ($USD336.98K) is about average for companies of similar size in the Australian market ($USD283.29K).
Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.
CEO
Michael Winlo
5.2yrs
Tenure
AU$542,066
Compensation
Dr. Michael Winlo serves as Managing Director of Emyria Limited (formerly known as Emerald Clinics Limited) since November 26, 2019 and served as its Chief Executive Officer until November 26, 2019. Dr. Wi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 5.2yrs | AU$542.07k | 0.23% A$ 35.6k | |
| Executive Medical Director & Director | 5.8yrs | AU$485.37k | no data | |
| Chief Financial Officer | no data | no data | no data | |
| Head of Research & Drug Development | no data | no data | no data | |
| Head of Corporate Operations | no data | no data | no data | |
| Company Secretary | 1.8yrs | no data | no data |
5.2yrs
Average Tenure
Experienced Management: EMD's management team is seasoned and experienced (5.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 5.2yrs | AU$542.07k | 0.23% A$ 35.6k | |
| Executive Medical Director & Director | 5.2yrs | AU$485.37k | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Non-Executive Chairman | 1.2yrs | AU$85.64k | 1.41% A$ 221.0k | |
| Member of Medical Advisory Board & Independent Non-Executive Director | 4.9yrs | AU$50.00k | no data | |
| Non-Executive Director | 1.4yrs | AU$180.54k | no data | |
| Non-Executive Director & Chairman of Strategic Advisory Board | 3.9yrs | AU$116.31k | 0.14% A$ 21.5k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | 3.9yrs | no data | no data |
3.9yrs
Average Tenure
56yo
Average Age
Experienced Board: EMD's board of directors are considered experienced (3.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 04:25 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Emyria Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|